New Pathways and Chemotherapeutic Delivery Mechanisms in the Treatment of Metastatic Breast Cancer
Metastatic breast cancer (mBC) remains the leading cause of cancer-related death in women. Chemotherapy remains the backbone of mBC treatment; however, new developments across the therapeutic spectrum are expanding clinical approaches to care. Among chemotherapy agents, efforts are underway to improve delivery mechanisms, efficacy, and toxicity profiles, with a shift towards oral therapy, but how do we balance value, costs and health improvements?
Join AJMC® on December 17 at 3pm and 5 pm ET to gain insights from leaders from West Cancer Center and Stanford Cancer Centers as they discuss the shifting treatment paradigm in mBC and their approach to ensuring success with oral therapy.
December 17th 2020, 3:00 pm EST